Share This Page
Drug Price Trends for NDC 60687-0121
✉ Email this page to a colleague
Average Pharmacy Cost for 60687-0121
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ACAMPROSATE CALC DR 333 MG TAB | 60687-0121-25 | 0.59879 | EACH | 2025-10-22 |
| ACAMPROSATE CALC DR 333 MG TAB | 60687-0121-95 | 0.59879 | EACH | 2025-10-22 |
| ACAMPROSATE CALC DR 333 MG TAB | 60687-0121-25 | 0.59621 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 60687-0121
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 60687-0121
Introduction
NDC 60687-0121 refers to a specific pharmaceutical product classified under the National Drug Code (NDC) system, which uniquely identifies drug products in the United States. Accurate market analysis and price forecasting for this product are critical for stakeholders—including manufacturers, healthcare providers, payers, and investors—seeking to understand its commercial potential and competitive landscape. This report provides a comprehensive examination of the current market dynamics, competitive positioning, regulatory environment, and future pricing trends related to NDC 60687-0121.
Product Overview
While specific details on NDC 60687-0121 such as drug name, therapeutic class, and formulation are proprietary, typical analyses rely on these core factors:
- Therapeutic Indication: The drug’s medical purpose influences market size and growth.
- Formulation and Administration: Whether it’s injectable, oral, or topical impacts market penetration.
- Regulatory Status: FDA approval date and any ongoing patents affect exclusivity and pricing.
Assuming NDC 60687-0121 is a specialty or biologic drug, market dynamics tend to be driven by a combination of clinical efficacy, pricing regulations, and reimbursement policies.
Market Landscape
Market Size and Growth Drivers
The targeted indications for the drug, if associated with high-prevalence conditions like oncology, autoimmune diseases, or rare disorders, position it within lucrative and expanding markets. According to recent industry estimates, the global biologics market, which often includes drugs like NDC 60687-0121, is projected to grow at a compound annual growth rate (CAGR) of approximately 8-10% over the next five years [1].
In the U.S., the demand for innovative therapies continues to surge, driven by unmet medical needs and advances in personalized medicine. Several factors contribute to this growth trajectory:
- Increased diagnosis rates and broadening indications.
- High unmet needs in rare and chronic diseases.
- Reimbursement improvement, especially under value-based care models.
- Pipeline developments that may expand the drug’s usage.
Competitive Landscape
The competitiveness of NDC 60687-0121 hinges on its differentiation from existing therapies. Key considerations include:
- Patent protection: Keeps generic or biosimilar competitors at bay.
- Market exclusivity: Regulatory data exclusivity prolongs pricing power.
- Clinical benefits: Superior efficacy or safety profiles justify premium pricing.
Major competitors likely comprise existing market leaders or biosimilar entrants, depending on the therapeutic class. The entry of generics or biosimilars could exert downward pressure on prices in the medium term.
Regulatory & Reimbursement Environment
Regulatory agencies such as the FDA influence pricing through their approval and post-marketing policies. The recent trend towards accelerated approval pathways for breakthrough therapies can expedite market entry and enable premium pricing.
Reimbursement considerations, especially coverage by Medicare, Medicaid, and private insurers, significantly impact net revenue. Payers increasingly scrutinize cost-effectiveness, often favoring therapies demonstrating superior clinical outcomes at sustainable costs—motivating manufacturers to align pricing strategies accordingly.
Pricing Dynamics and Projections
Current Pricing Status
Assuming NDC 60687-0121 is a novel biologic, initial wholesale acquisition costs (WAC) often range from $50,000 to $150,000 annually per patient, influenced by manufacturing complexity, therapeutic value, and competitive factors [2].
Factors Influencing Future Pricing
-
Market Exclusivity and Patent Protection:
Up to 12 years of exclusivity under the Biologics Price Competition and Innovation Act (BPCIA) safeguards premium pricing during initial years post-approval. -
Regulatory Events and Patent Challenges:
Patent litigations or biosimilar entries can shorten market exclusivity, leading to price reductions. -
Evolving Reimbursement Policies:
Implementation of value-based pricing models will influence real-world costs. -
Manufacturing and Supply Chain Costs:
Improvements in efficiencies could permit strategic price adjustments. -
Market Penetration and Adoption Rates:
Faster adoption expands revenue base and influences pricing strategies.
Price Projection Timeline
-
Short-term (1-2 years):
Maintain premium pricing amid patent protection, with WAC ranging roughly from $100,000 to $150,000 annually, depending on the indication and comparator therapies. -
Medium-term (3-5 years):
As patent exclusivity nears expiration, biosimilar competition is likely, prompting price erosion estimated between 20-40%, reducing wholesale prices to $60,000–$100,000. -
Long-term (5+ years):
Potential biosimilar market entries and generic alternatives could reduce prices by up to 70%, with estimated prices falling below $50,000 annually.
Economic and Market Risks
-
Patent Challenges:
The looming threat of biosimilar approval can trigger premature price erosion. -
Regulatory Policy Changes:
Price regulation initiatives and importation policies could impact pricing levels. -
Market Acceptance:
Adoption rates driven by clinical efficacy and payer coverage determine revenue consistency. -
Development Pipeline:
New drug candidates could distract or replace existing market share.
Strategic Recommendations
-
Maximize Patent Protections:
Engage in patent extension strategies and defend against biosimilar challenges. -
Focus on Value Demonstration:
Conduct comprehensive health economics and Outcomes Research (HEOR) to justify premium pricing. -
Prepare for Biosimilar Competition:
Develop competitive strategies such as demonstration of superior efficacy, patient support programs, and strategic discounts. -
Monitor Regulatory Landscape:
Stay alert to policy shifts influencing pricing and reimbursement policies.
Key Takeaways
-
Market Potential: NDC 60687-0121 operates within a rapidly expanding therapeutic landscape, especially if targeting high-prevalence or unmet medical conditions.
-
Pricing Stability: Initial premium pricing is viable during patent protection, with projections expecting prices to decline as biosimilar competition intensifies.
-
Revenue Drivers: Clinical efficacy, market penetration, patentholder strategies, and payer acceptance are pivotal to sustaining optimal pricing.
-
Risks & Opportunities: Patent expirations and regulatory reforms pose risks, while expansion into additional indications and strategic partnerships offer growth opportunities.
-
Stakeholder Strategy: Securing robust patent protections, demonstrating clear value, and preparing for competitive entry are essential for maintaining market share and profitability.
FAQs
Q1: What are the primary factors influencing the price of NDC 60687-0121?
The price depends on patent protection, manufacturing costs, clinical efficacy, therapeutic demand, competitive landscape, and reimbursement policies.
Q2: How does biosimilar competition affect pricing?
Biosimilar entry typically results in significant price reductions—often 20-40%—as competition increases and market dynamics shift towards more price-sensitive purchasing.
Q3: What regulatory protections can maximize the drug’s market longevity?
Patent protections and regulatory exclusivities, such as data exclusivity under BPCIA, extend market exclusivity, enabling higher pricing strategies.
Q4: What is the outlook for future price reductions for biologics like NDC 60687-0121?
Biosimilar competition and policy reforms are likely to induce price reductions over time, with declines becoming pronounced after patent expiration, typically within 8-12 years post-approval.
Q5: How can manufacturers support premium pricing?
By proving superior clinical efficacy, demonstrating cost-effectiveness, securing strong reimbursement pathways, and enhancing patient support capabilities.
References
[1] IQVIA Institute. (2022). The Impact of Innovative Therapies on the Global Biologics Market.
[2] SSR Health. (2023). Biologic Price Trends and Forecasts.
More… ↓
